Topic: Beckman Coulter Inc.
Beckman Coulter's 4th-quarter profit falls on charges, 2010 outlook reaffirmedMedical-testing instruments maker Beckman Coulter Inc. said Thursday its fourth-quarter profit fell 14.5 percent on costs for the buyout of Olympus Corp.'s lab-based diagnostics
Beckman Coulter forecasts 2010 earnings per share below Wall Street expectationsBeckman Coulter Inc. on Thursday forecast a sharp increase in 2010 profit but the outlook still fell below Wall Street expectations.The biomedical test equipment manufacturer
Beckman Coulter announces stock, senior note offerings expected to generate $750 millionBiomedical diagnostics instrument maker Beckman Coulter Inc. on Monday announced the pricing of a public stock offering and two senior note offerings expected to gener